Complete pathologic response to neoadjuvant radiotherapy is predictive of oncological outcome in patients with soft tissue sarcoma

Anticancer Research

Volumn 32, Issue 9, 2012, Pages 3911-3916

  Shah, Dhruvil ^a   Borys, Dariusz ^a   Martinez, Steve R ^a   Li, Chin Shang ^b   Tamurian, Robert M ^a   Bold, Richard J ^a   Monjazeb, Arta ^a   Canter, Robert J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Preoperative radiotherapy; Soft tissue sarcoma; Survival; Tumor necrosis

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISTANT RECURRENCE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LOCAL RECURRENCE FREE SURVIVAL; MALE; MONOTHERAPY; OVERALL SURVIVAL; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; SOFT TISSUE SARCOMA; SURVIVAL RATE; SURVIVAL TIME; TREATMENT RESPONSE; TUMOR NECROSIS;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NECROSIS; NEOADJUVANT THERAPY; PROGNOSIS; RADIOTHERAPY, ADJUVANT; SARCOMA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84867020399     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. O'Sullivan B, Davis AM, Turcotte R, Bell R, Catton C, Chabot P, Wunder J, Kandel R, Goddard K, Sadura A, Pater J and Zee B: Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: A randomised trial. Lancet 359: 2235-2241, 2002. (Pubitemid 34717977)
2. Wunder JS, Nielsen TO, Maki RG, O'Sullivan B and Alman BA: Opportunities for improving the therapeutic ratio for patients with sarcoma. Lancet Oncol 8: 513-524, 2007. (Pubitemid 46823060)
3. Pisters PW, O'Sullivan B and Maki RG: Evidence-based recommendations for local therapy for soft tissue sarcomas. J Clin Oncol 25: 1003-1008, 2007. (Pubitemid 350002867)
4. Benjamin RS: SARC-CTOS imaging symposium: introduction to the problem from a clinical perspective. Oncologist 13(Suppl2): 1-3, 2008.
5. Schuetze SM, Baker LH, Benjamin RS, Canetta R: Selection of response criteria for clinical trials of sarcoma treatment. Oncologist 13(Suppl 2): 32-40, 2008.
6. Eilber FC, Rosen G, Eckardt J, Forscher C, Nelson SD, Selch M, Dorey F and Eilber FR: Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas. J Clin Oncol 19: 3203-3209, 2001. (Pubitemid 32591437)
7. Hew L, Kandel R, Davis A, O'Sullivan B, Catton C and Bell R: Histological necrosis in soft tissue sarcoma following preoperative irradiation. J Surg Oncol 57: 111-114, 1994. (Pubitemid 24299659)
8. Macdermed DM, Miller LL, Peabody TD, Simon MA, Luu HH, Haydon RC, Montag AG, Undevia SD and Connell PP: Primary tumor necrosis predicts distant control in locally advanced soft-tissue sarcomas after preoperative concurrent chemoradiotherapy. Int J Radiat Oncol Biol Phys 76: 1147-1153, 2010.
9. Mansour JC and Schwarz RE: Pathologic response to preoperative therapy: Does it mean what we think it means? Ann Surg Oncol 16: 1465-1479, 2009.
10. Picci P, Bohling T, Bacci G, Ferrari S, Sangiorgi L, Mercuri M, Ruggieri P, Manfrini M, Ferraro A, Casadei R, Benassi MS, Mancini AF, Rosito P, Cazzola A, Barbieri E, Tienghi A, Brach del Prever A, Comandone A, Bacchini P and Bertoni F: Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities. J Clin Oncol 15:1553-1559, 1997. (Pubitemid 27167392)
11. Ryan CW, Montag AG, Hosenpud JR, Samuels B, Hayden JB, Hung AY, Mansoor A, Peabody TD, Mundt AJ and Undevia S: Histologic response of dose-intense chemotherapy with preoperative hypofractionated radiotherapy for patients with high-risk soft tissue sarcomas. Cancer 112: 2432-2439, 2008.
12. Wiklund T, Saeter G, Strander H, Alvegard T and Blomqvist C: The outcome of advanced soft tissue sarcoma patients with complete tumour regression after either chemotherapy alone or chemotherapy plus surgery. The Scandinavian Sarcoma Group experience. Eur J Cancer 33: 357-361, 1997. (Pubitemid 27168059)
13. Willett CG, Schiller AL, Suit HD, Mankin HJ and Rosenberg A: The histologic response of soft tissue sarcoma to radiation therapy. Cancer 60: 1500-1504, 1987. (Pubitemid 17141001)
14. Coindre JM: Grading of soft tissue sarcomas: review and update. Arch Pathol Lab Med 130: 1448-1453, 2006.
15. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966.
16. Yang JC, Chang AE, Baker AR, Sindelar WF, Danforth DN, Topalian SL, DeLaney T, Glatstein E, Steinberg SM, Merino MJ and Rosenberg SA: Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 16: 197-203, 1998. (Pubitemid 28041599)
17. Canter RJ, Qin LX, Ferrone CR, Maki RG, Singer S and Brennan MF: Why do patients with low-grade soft tissue sarcoma die? Ann Surg Oncol 15: 3550-3560, 2008.
18. Zlotecki RA, Katz TS, Morris CG, Lind DS and Hochwald SN: Adjuvant radiation therapy for resectable retroperitoneal soft tissue sarcoma: the University of Florida experience. Am J Clin Oncol 28: 310-316, 2005. (Pubitemid 40800485)
19. Kraybill WG, Harris J, Spiro IJ, Ettinger DS, DeLaney TF, Blum RH, Lucas DR, Harmon DC, Letson GD and Eisenberg B: Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514. J Clin Oncol 24: 619-625, 2006. (Pubitemid 46630425)
20. DeLaney TF, Spiro IJ, Suit HD, Gebhardt MC, Hornicek FJ, Mankin HJ, Rosenberg AL, Rosenthal DI, Miryousefi F, Ancukiewicz M and Harmon DC: Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas. Int J Radiat Oncol Biol Phys 56: 1117-1127, 2003. (Pubitemid 36794046)
21. Curtis KK, Ashman JB, Beauchamp CP, Schwartz AJ, Callister MD, Dueck AC, Gunderson LL and Fitch TR: Neoadjuvant chemoradiation compared to neoadjuvant radiation alone and surgery alone for Stage II and III soft tissue sarcoma of the extremities. Radiat Oncol 6: 91, 2011.
22. Katz SC and Brennan MF: Randomized clinical trials in soft tissue sarcoma. Surg Oncol Clin N Am 19: 1-11, 2010.
23. Potter DA, Glenn J, Kinsella T, Glatstein E, Lack EE, Restrepo C, White DE, Seipp CA, Wesley R and Rosenberg SA: Patterns of recurrence in patients with high-grade soft-tissue sarcomas. J Clin Oncol 3: 353-366, 1985. (Pubitemid 15132003)